Ginkgo Bioworks
DNA
DNA
315 hedge funds and large institutions have $2.25B invested in Ginkgo Bioworks in 2023 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 121 increasing their positions, 62 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.1% more ownership
Funds ownership: 1.81% → 1.91% (+0.1%)
23% less call options, than puts
Call options by funds: $5.42M | Put options by funds: $7.03M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
315
Holding in Top 10
2
Calls
$5.42M
Puts
$7.03M
Top Buyers
| 1 | +$26M | |
| 2 | +$25.8M | |
| 3 | +$12.1M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$12.1M |
| 5 |
Millennium Management
New York
|
+$10.8M |
Top Sellers
| 1 | -$16.2M | |
| 2 | -$4.5M | |
| 3 | -$3.47M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$3.25M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$2.65M |